Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) EBT: 2020-2025

Historic EBT for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$2.3 million.

  • Journey Medical's EBT rose 3.14% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year increase of 53.09%. This contributed to the annual value of -$14.6 million for FY2024, which is 302.29% down from last year.
  • According to the latest figures from Q3 2025, Journey Medical's EBT is -$2.3 million, which was up 38.04% from -$3.7 million recorded in Q2 2025.
  • Journey Medical's 5-year EBT high stood at $16.9 million for Q3 2023, and its period low was -$15.3 million during Q2 2021.
  • Its 3-year average for EBT is -$2.6 million, with a median of -$3.4 million in 2024.
  • As far as peak fluctuations go, Journey Medical's EBT crashed by 27,063.46% in 2021, and later spiked by 267.67% in 2023.
  • Quarterly analysis of 5 years shows Journey Medical's EBT stood at -$13.4 million in 2021, then climbed by 20.77% to -$10.6 million in 2022, then spiked by 81.02% to -$2.0 million in 2023, then skyrocketed by 178.43% to $1.6 million in 2024, then rose by 3.14% to -$2.3 million in 2025.
  • Its EBT was -$2.3 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$4.1 million in Q1 2025.